Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction

Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: Data from the Heart and Soul Study

(2012) Ruth Dubin et al.   AMERICAN HEART JOURNAL

High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome

(2012) Aydogan Aydogdu et al.   GYNECOLOGICAL ENDOCRINOLOGY

PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR

(2012) V. Cozzi et al.   PLACENTA

Mechanisms of Endothelial Dysfunction in Resistance Arteries from Patients with End-Stage Renal Disease

(2012) Leanid Luksha et al.   PLoS One

Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity

(2011) O. Osorio-Conles et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Pentraxin 3: A novel and independent prognostic marker in ischemic stroke

(2011) Wi-Sun Ryu et al.   ATHEROSCLEROSIS

Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications

(2011) Paweł CieŚlik et al.   AUTOIMMUNITY

Soluble TWEAK and PTX3 in Nondialysis CKD Patients: Impact on Endothelial Dysfunction and Cardiovascular Outcomes

(2011) M. I. Yilmaz et al.   Clinical Journal of the American Society of Nephrology

Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease

(2011) T. Miyamoto et al.   Clinical Journal of the American Society of Nephrology

Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD

(2011) J. J. Carrero et al.   Clinical Journal of the American Society of Nephrology

Impaired resistance artery function in patients with end-stage renal disease

(2011) Natallia Luksha et al.   CLINICAL SCIENCE

Pentraxins and Atherosclerosis: The Role of PTX3

(2011) Cecilia Garlanda et al.   CURRENT PHARMACEUTICAL DESIGN

Is Pentraxin 3 Involved in Obesity-Induced Decrease in Arterial Distensibility?

(2011) Asako Miyaki et al.   Journal of Atherosclerosis and Thrombosis

Number of Endothelial Progenitor Cells in Peripheral Artery Disease as a Marker of Severity and Association with Pentraxin-3, Malondialdehyde-Modified Low-Density Lipoprotein and Membrane Type-1 Matrix Metalloproteinase

(2011) Tetsuji Morishita et al.   Journal of Atherosclerosis and Thrombosis

Pentraxin 3 as a biomarker for acute coronary syndrome: Comparison with biomarkers for cardiac damage

(2011) Noriaki Kume et al.   Journal of Cardiology

Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients

(2010) A. Witasp et al.   JOURNAL OF INTERNAL MEDICINE

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease

(2010) P. Stenvinkel   JOURNAL OF INTERNAL MEDICINE

Reciprocal Contribution of Pentraxin 3 and C-Reactive Protein to Obesity and Metabolic Syndrome

(2010) Tsuneo Ogawa et al.   Obesity

Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?

(2010) Juan J. Carrero et al.   SEMINARS IN DIALYSIS

Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease

(2010) Vladimír Teplan et al.   WIENER KLINISCHE WOCHENSCHRIFT

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

(2009) Giuseppe Danilo Norata et al.   CIRCULATION

Effect of Renin Angiotensin System Blockade on Pentraxin 3 Levels in Type-2 Diabetic Patients With Proteinuria

(2009) M. I. Yilmaz et al.   Clinical Journal of the American Society of Nephrology

Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis

(2009) A. C. Cordeiro et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease

(2009) Tomas Roubicek et al.   NUTRITION

Waist Circumference and Visceral Fat in CKD: A Cross-sectional Study

(2008) Fabiana M.R. Sanches et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors

(2008) L. Alberti et al.   ATHEROSCLEROSIS

Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction

(2008) Monica Salio et al.   CIRCULATION

Novel Links between the Long Pentraxin 3, Endothelial Dysfunction, and Albuminuria in Early and Advanced Chronic Kidney Disease

(2008) M. E. Suliman et al.   Clinical Journal of the American Society of Nephrology

Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?

(2008) P. Stenvinkel et al.   Clinical Journal of the American Society of Nephrology

Pentraxins, humoral innate immunity and tissue injury

(2008) Angelo A Manfredi et al.   CURRENT OPINION IN IMMUNOLOGY

Expression of Six Transmembrane Protein of Prostate 2 in Human Adipose Tissue Associates with Adiposity and Insulin Resistance

(2008) Peter Arner et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Oxidative Stress and Inflammation Are Associated with Adiposity in Moderate to Severe CKD

(2008) L. F. Ramos et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality

(2008) M.E. Suliman et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites

(2007) Leanid Luksha et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY